RGCC and breast neoplasm: Additionally, we found that the RGC32 promoter methylation was not different between breast tumorous tissues and nontumorous tissues, although the methylated phenotype was observed more frequently in tumorous tissues than in nontumorous breast tissues (4.8% versus 0).